Diagnosis, comorbidities, and management of restless legs syndrome

Current Medical Research and Opinion

Volumn 30, Issue 8, 2014, Pages 1441-1460

  Becker, Philip M ^a,b   Novak, Marta ^c,d  

^a Sleep Medicine Associates of Texas PA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Comorbidities; Depression; End stage renal disease; Insomnia; Pain; Pregnancy; Restless legs syndrome

Indexed keywords

ALCOHOL; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CARBIDOPA PLUS LEVODOPA; CODEINE; ESZOPICLONE; GABAPENTIN; GABAPENTIN ENACARBIL; HYDROCODONE; METHADONE; OXYCODONE; PRAMIPEXOLE; PREGABALIN; ROPINIROLE; ROTIGOTINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; ZALEPON; ZOLPIDEM;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR DISEASE; COMORBIDITY; DEPRESSION; END STAGE RENAL DISEASE; ERECTILE DYSFUNCTION; FIBROMYALGIA; HEART DISEASE; HUMAN; INSOMNIA; IRON DEFICIENCY; KIDNEY DISEASE; LIVER DISEASE; MENTAL DISEASE; MIGRAINE; MOOD DISORDER; MULTIPLE SCLEROSIS; NARCOLEPSY; NEUROPATHY; OBESITY; PAIN; PARKINSON DISEASE; POLYNEUROPATHY; PREGNANCY; PSYCHOGENIC PAIN; RESTLESS LEGS SYNDROME; REVIEW; RHEUMATOID ARTHRITIS; SLEEP DISORDER; UREMIA; COMPLICATION; DIFFERENTIAL DIAGNOSIS; DISEASE MANAGEMENT; MULTIMODALITY CANCER THERAPY;

COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS; RESTLESS LEGS SYNDROME;

EID: 84904876356     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2014.918029     Document Type: Review

References (220)

1. Earley CJ, Silber MH. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med 2010;11:807-15
2. Innes KE, Selfe TK, Agarwal P. Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review. Sleep Med Rev 2012;16:309-39
3. Li Y, Wang W, Winkelman JW, et al. Prospective study of restless legs syndrome and mortality among men. Neurology 2013;81:52-9
4. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord 2007;22(Suppl 18):S440-8
5. Freeman AA, Rye DB. The molecular basis of restless legs syndrome. Curr Opin Neurobiol 2013, 23, 895-900.
6. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19
7. Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004;5:237-46
8. Allen RP, Stillman P, Myers AJ. Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics. Sleep Med 2010;11:31-7
9. Koo YS, Lee GT, Lee SY, et al. Topography of sensory symptoms in patients with drug-naïve restless legs syndrome. Sleep Med 2013;14:1369-74
10. Buchfuhrer MJ. Restless legs syndrome (RLS) with expansion of symptoms to the face. Sleep Med 2008;9:188-90
11. International Restless Legs Syndrome Study Group. Revised IRLSSG Diagnostic Criteria for RLS. 2012. Available at: http://irlssg.org/ diagnosticcriteria/[Last accessed November 2013]
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association, 2013:410-13
13. Chaudhuri KR, Forbes A, Grosset D, et al. Diagnosing restless legs syndrome (RLS) in primary care. Curr Med Res Opin 2004;20:1785-95
14. Montplaisir J, Boucher S, Poirier G, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-5
15. Allen RP, Earley CJ. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 2000;1:11-19
16. Benes H, Walters AS, Allen RP, et al. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord 2007;22(Suppl 18):S401-8
17. Coleman RM, Roffwarg HP, Kennedy SJ, et al. Sleep-wake disorders based on a polysomnographic diagnosis. A national cooperative study. JAMA 1982;247:997-1003
18. Bassetti CL, Mauerhofer D, Gugger M, et al. Restless legs syndrome: a clinical study of 55 patients. Eur Neurol 2001;45:67-74
19. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165: 1286-92
20. Bjorvatn B, Leissner L, Ulfberg J, et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med 2005;6:307-12
21. Ulfberg J, Bjorvatn B, Leissner L, et al. Comorbidity in restless legs syndrome among a sample of Swedish adults. Sleep Med 2007;8:768-72
22. Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006;129:76-80
23. Broman JE, Mallon L, Hetta J. Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: epidemiological survey in Sweden. Psychiatr Clin Neurosci 2008;62:472-5
24. Hornyak M, Feige B, Voderholzer U, et al. Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study. Sleep 2007;30:861-5
25. Saletu B, Anderer P, Saletu M, et al. EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls. Sleep Med 2002;3(Suppl):S35-42
26. Winkelman JW, Redline S, Baldwin CM, et al. Polysomnographic and healthrelated quality of life correlates of restless legs syndrome in the Sleep Heart Health Study. Sleep 2009;32:772-8
27. Budhiraja P, Budhiraja R, Goodwin JL, et al. Incidence of restless legs syndrome and its correlates. J Clin Sleep Med 2012;8:119-24
28. Chokroverty S. Long-term management issues in restless legs syndrome. Mov Disord 2011;26:1378-85
29. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000;54:1064-8
30. Ulfberg J, Nyström B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001;16: 1159-63
31. Sukegawa T, Itoga M, Seno H, et al. Sleep disturbances and depression in the elderly in Japan. Psychiatr Clin Neurosci 2003;57:265-70
32. Sevim S, Dogu O, Kaleagasi H, et al. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatr 2004;75:226-30
33. Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006;7:545-52
34. Lee HB, Hening WA, Allen RP, et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatr Clin Neurosci 2008;20:101-5
35. Cho SJ, Hong JP, Hahm BJ, et al. Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep 2009;32:1069-76
36. Kim J, Choi C, Shin K, et al. Prevalence of restless legs syndrome and associated factors in the Korean adult population: the Korean Health and Genome Study. Psychiatr Clin Neurosci 2005;59:350-3
37. Kim WH, Kim BS, Kim SK, et al. Restless legs syndrome in older people: a community-based study on its prevalence and association with major depressive disorder in older Korean adults. Int J Geriatr Psychiatry 2012;27:565-72
38. Wesstrom J, Nilsson S, Sundstrom-Poromaa I, Ulfberg J. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric 2008;11:422-8
39. Nomura T, Inoue Y, Kusumi M, et al. Prevalence of restless legs syndrome in a rural community in Japan. Mov Disord 2008;23:2363-9
40. Kim KW, Yoon IY, Chung S, et al. Prevalence, comorbidities and risk factors of restless legs syndrome in the Korean elderly population - results from the Korean Longitudinal Study on Health and Aging. J Sleep Res 2010;19:87-92
41. Mosko S, Zetin M, Glen S, et al. Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients. J Clin Psychol 1989;45:51-60
42. Banno K, Delaive K, Walld R, Kryger MH. Restless legs syndrome in 218 patients: associated disorders. Sleep Med 2000;1:221-9
43. Vandeputte M, de Weerd A. Sleep disorders and depressive feelings: a global survey with the Beck depression scale. Sleep Med 2003;4:343-5
44. Winkelmann J, Prager M, Lieb R, et al. 'Anxietas tibiarum'. Depression and anxiety disorders in patients with restless legs syndrome. J Neurol 2005;252:67-71
45. Aguera-Ortiz L, Perez MI, Osorio RS, et al. Prevalence and clinical correlates of restless legs syndrome among psychogeriatric patients. Int J Geriatr Psychiatry 2011;26:1252-9
46. Li Y, Mirzaei F, O'Reilly EJ, et al. Prospective study of restless legs syndrome and risk of depression in women. Am J Epidemiol 2012;176:279-88
47. Hornyak M. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs 2010;24:89-98
48. Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005;28:891-8
49. Gupta R, Lahan V, Goel D. A study examining depression in restless legs syndrome. Asian J Psychiatr 2013;6:308-12
50. Szentkiralyi A, Volzke H, Hoffmann W, et al. The relationship between depressive symptoms and restless legs syndrome in two prospective cohort studies. Psychosom Med 2013;75:359-65
51. Szentkiralyi A, Molnar MZ, Czira ME, et al. Association between restless legs syndrome and depression in patients with chronic kidney disease. J Psychosom Res 2009;67:173-80
52. Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatr 2005;58:510-14
53. Rottach KG, Schaner BM, Kirch MH, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 2008;43:70-5
54. Brown LK, Dedrick DL, Doggett JW, Guido PS. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med 2005;6:443-50
55. Leutgeb U, Martus P. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants. Eur J Med Res 2002;7:368-78
56. Ferini-Strambi L, Walters AS, Sica D. The relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease. J Neurol 2013 [Epub ahead of print]
57. Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep 2009;32:589-97
58. Siddiqui F, Strus J, Ming X, et al. Rise of blood pressure with periodic limb movements in sleep and wakefulness. Clin Neurophysiol 2007;118:1923-30
59. Juuti AK, Laara E, Rajala U, et al. Prevalence and associated factors of restless legs in a 57-year-old urban population in northern Finland. Acta Neurol Scand 2010;122:63-9
60. Berger K, Luedemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004;164: 196-202
61. Moller C, Wetter TC, Koster J, Stiasny-Kolster K. Differential diagnosis of unpleasant sensations in the legs: prevalence of restless legs syndrome in a primary care population. Sleep Med 2010;11:161-6
62. Mallon L, Broman JE, Hetta J. Restless legs symptoms with sleepiness in relation to mortality: 20-year follow-up study of a middle-aged Swedish population. Psychiatr Clin Neurosci 2008;62:457-63
63. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002;53:547-54
64. Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004;56:497-502
65. Alattar M, Harrington JJ, Mitchell CM, Sloane P. Sleep problems in primary care: a North Carolina Family Practice Research Network (NC-FP-RN) study. J Am Board Fam Med 2007;20:365-74
66. Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008;70:35-42
67. Benediktsdottir B, Janson C, Lindberg E, et al. Prevalence of restless legs syndrome among adults in Iceland and Sweden: Lung function, comorbidity, ferritin, biomarkers and quality of life. Sleep Med 2010;11:1043-8
68. Lee HB, Hening WA, Allen RP, et al. Race and restless legs syndrome symptoms in an adult community sample in east Baltimore. Sleep Med 2006;7:642-5
69. Winter AC, Schürks M, Glynn RJ, et al. Vascular risk factors, cardiovascular disease, and restless legs syndrome in women. Am J Med 2013;126:220-7, 27 e1-2
70. Winter AC, Berger K, Glynn RJ, et al. Vascular risk factors, cardiovascular disease, and restless legs syndrome in men. Am J Med 2013;126:228-35, 35 e1-2
71. Elwood P, Hack M, Pickering J, et al. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health 2006;60:69-73
72. Li Y, Walters AS, Chiuve SE, et al. Prospective study of restless legs syndrome and coronary heart disease among women. Circulation 2012;126:1689-94
73. Winter AC, Schürks M, Glynn RJ, et al. Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study. BMJ Open 2012;2:e000866
74. Szentkiralyi A, Volzke H, Hoffmann W, et al. A time sequence analysis of the relationship between cardiovascular risk factors, vascular diseases and restless legs syndrome in the general population. J Sleep Res 2013;22:434-42
75. Aigner M, Prause W, Freidl M, et al. High prevalence of restless legs syndrome in somatoform pain disorder. Eur Arch Psychiatr Clin Neurosci 2007;257:54-7
76. Hornyak M, Sohr M, Busse M, 604 and 615 Study groups. Evaluation of painful sensory symptoms in restless legs syndrome: experience from two clinical trials. Sleep Med 2011;12:186-9
77. Nineb A, Rosso C, Dumurgier J, et al. Restless legs syndrome is frequently overlooked in patients being evaluated for polyneuropathies. Eur J Neurol 2007;14:788-92
78. Gemignani F, Brindani F, Negrotti A, et al. Restless legs syndrome and polyneuropathy. Mov Disord 2006;21:1254-7
79. Hattan E, Chalk C, Postuma RB. Is there a higher risk of restless legs syndrome in peripheral neuropathy? Neurology 2009;72:955-60
80. Rajabally YA, Shah RS. Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2010;42:252-6
81. Rutkove SB, Matheson JK, Logigian EL. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve 1996;19:670-2
82. O'Hare JA, Abuaisha F, Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir J Med Sci 1994;163:132-5
83. Gemignani F, Brindani F, Vitetta F, et al. Restless legs syndrome in diabetic neuropathy: a frequent manifestation of small fiber neuropathy. J Peripheral Nervous System 2007;12:50-3
84. Polydefkis M, Allen RP, Hauer P, et al. Subclinical sensory neuropathy in lateonset restless legs syndrome. Neurology 2000;55:1115-21
85. Gemignani F, Brindani F, Vitetta F, Marbini A. Restless legs syndrome and painful neuropathy - retrospective study. A role for nociceptive deafferentation? Pain Med 2009;10:1481-6
86. Gemignani F, Vitetta F, Brindani F, et al. Painful polyneuropathy associated with restless legs syndrome. Clinical features and sensory profile. Sleep Med 2013;14:79-84
87. Saletu B, Brandstätter N, Frey R, et al. [Clinical aspects of sleep disorders - experiences with 817 patients of an ambulatory sleep clinic; comment]. Wien Klin Wochenschr 1997;109:390-9
88. Reynolds G, Blake DR, Pall HS, Williams A. Restless leg syndrome and rheumatoid arthritis. Br Med J (Clinical Research Ed) 1986;292:659-60
89. Salih AM, Gray RE, Mills KR, Webley M. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br J Rheumatol 1994;33:60-3
90. Taylor-Gjevre RM, Gjevre JA, Skomro R, Nair B. Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol 2009;15:12-15
91. Stehlik R, Arvidsson L, Ulfberg J. Restless legs syndrome is common among female patients with fibromyalgia. Eur Neurol 2009;61:107-11
92. Viola-Saltzman M, Watson NF, Bogart A, et al. High prevalence of restless legs syndrome among patients with fibromyalgia: a controlled cross-sectional study. J Clin Sleep Med 2010;6:423-7
93. Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 2005;52:2495-505
94. Zoppi M, Maresca M. Symptoms accompanying fibromyalgia. Reumatismo 2008;60:217-20
95. Frauscher B, Gschliesser V, Brandauer E, et al. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. Sleep Med 2009;10:611-15
96. Akyol A, Kiylioglu N, Kadikoylu G, et al. Iron deficiency anemia and restless legs syndrome: is there an electrophysiological abnormality? Clin Neurol Neurosurg 2003;106:23-7
97. Allen RP, Auerbach S, Bahrain H, et al. The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia. Am J Hematol 2013;88:261-4
98. Allen RP, Burchell BJ, MacDonald B, et al. Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey. Sleep Med 2009;10:1097-100
99. Spencer BR, Kleinman S, Wright DJ, et al. Restless legs syndrome, pica, and iron status in blood donors. Transfusion 2013;53:1645-52
100. Arunthari V, Kaplan J, Fredrickson PA, et al. Prevalence of restless legs syndrome in blood donors. Mov Disord 2010;25:1451-5
101. Ulfberg J, Nystrom B. Restless legs syndrome in blood donors. Sleep Med 2004;5:115-18
102. Spencer B. Blood donor iron status: are we bleeding them dry? Curr Opin Hematol 2013;20:533-9
103. Burchell BJ, Allen RP, Miller JK, et al. RLS and blood donation. Sleep Med 2009;10:844-9
104. Bryant BJ, Yau YY, Arceo SM, et al. Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome. Transfusion 2013;53:1637-44
105. Balendran J, Champion D, Jaaniste T, Welsh A. A common sleep disorder in pregnancy: restless legs syndrome and its predictors. Aust NZ J Obstet Gynaecol 2011;51:262-4
106. Neau JP, Marion P, Mathis S, et al. Restless legs syndrome and pregnancy: follow-up of pregnant women before and after delivery. Eur Neurol 2010;64:361-6
107. Alves DA, Carvalho LB, Morais JF, Prado GF. Restless legs syndrome during pregnancy in Brazilian women. Sleep Med 2010;11:1049-54
108. Suzuki K, Ohida T, Sone T, et al. The prevalence of restless legs syndrome among pregnant women in Japan and the relationship between restless legs syndrome and sleep problems. Sleep 2003;26:673-7
109. Sikandar R, Khealani BA, Wasay M. Predictors of restless legs syndrome in pregnancy: a hospital based cross sectional survey from Pakistan. Sleep Med 2009;10:676-8
110. Uglane MT, Westad S, Backe B. Restless legs syndrome in pregnancy is a frequent disorder with a good prognosis. Acta Obstet Gynecol Scand 2011;90:1046-8
111. Hubner A, Krafft A, Gadient S, et al. Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study. Neurology 2013;80:738-42
112. Chen PH, Liou KC, Chen CP, Cheng SJ. Risk factors and prevalence rate of restless legs syndrome among pregnant women in Taiwan. Sleep Med 2012;13:1153-7
113. Manconi M, Govoni V, De Vito A, et al. Restless legs syndrome and pregnancy. Neurology 2004;63:1065-9
114. Lee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med 2001;10:335-41
115. Sarberg M, Josefsson A, Wirehn AB, Svanborg E. Restless legs syndrome during and after pregnancy and its relation to snoring. Acta Obstet Gynecol Scand 2012;91:850-5
116. Tunc T, Karadag YS, Dogulu F, Inan LE. Predisposing factors of restless legs syndrome in pregnancy. Mov Disord 2007;22:627-31
117. Dzaja A, Wehrle R, Lancel M, Pollmacher T. Elevated estradiol plasma levels in women with restless legs during pregnancy. Sleep 2009;32:169-74
118. Djokanovic N, Garcia-Bournissen F, Koren G. Medications for restless legs syndrome in pregnancy. J Obstet Gynaecol Can 2008;30:505-7
119. Gigli GL, Adorati M, Dolso P, et al. Restless legs syndrome in end-stage renal disease. Sleep Med 2004;5:309-15
120. Araujo SM, de Bruin VM, Nepomuceno LA, et al. Restless legs syndrome in end-stage renal disease: clinical characteristics and associated comorbidities. Sleep Med 2010;11:785-90
121. Takaki J, Nishi T, Nangaku M, et al. Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis 2003;41:833-9
122. Anand S, Johansen KL, Grimes B, et al. Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: the comprehensive dialysis study. Hemodial Int 2013;17:50-8
123. Merlino G, Lorenzut S, Gigli GL, et al. A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failure. Mov Disord 2010;25:1019-25
124. Lee J, Nicholl DD, Ahmed SB, et al. The prevalence of restless legs syndrome across the full spectrum of kidney disease. J Clin Sleep Med 2013;9:455-9
125. Aritake-Okada S, Nakao T, Komada Y, et al. Prevalence and clinical characteristics of restless legs syndrome in chronic kidney disease patients. Sleep Med 2011;12:1031-3
126. Quinn C, Uzbeck M, Saleem I, et al. Iron status and chronic kidney disease predict restless legs syndrome in an older hospital population. Sleep Med 2011;12:295-301
127. Enomoto M, Inoue Y, Namba K, et al. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients. Mov Disord 2008;23:811-16; quiz 926
128. Sloand JA, Shelly MA, Feigin A, et al. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis 2004;43:663-70
129. Besarab A, Coyne DW. Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol 2010;6:699-710
130. Huiqi Q, Shan L, Mingcai Q. Restless legs syndrome (RLS) in uremic patients is related to the frequency of hemodialysis sessions. Nephron 2000;86:540
131. Holley JL, Nespor S, Rault R. A comparison of reported sleep disorders in patients on chronic hemodialysis and continuous peritoneal dialysis. Am J Kidney Dis 1992;19:156-61
132. Roger SD, Harris DC, Stewart JH. Possible relation between restless legs and anaemia in renal dialysis patients. Lancet 1991;337:1551
133. Sabbatini M, Minale B, Crispo A, et al. Insomnia in maintenance haemodialysis patients. Nephrol, Dial, Transplant 2002;17:852-6
134. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 2002;17:1072-6
135. Mucsi I, Molnar MZ, Ambrus C, et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant 2005;20:571-7
136. Unruh ML, Levey AS, D'Ambrosio C, et al. Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. Am J Kidney Dis 2004;43:900-9
137. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in endstage renal disease. Am J Kidney Dis 1996;28:372-8
138. Molnar MZ, Szentkiralyi A, Lindner A, et al. Restless legs syndrome and mortality in kidney transplant recipients. Am J Kidney Dis 2007;50:813-20
139. Molnar MZ, Novak M, Szeifert L, et al. Restless legs syndrome, insomnia, and quality of life after renal transplantation. J Psychosom Res 2007;63: 591-7
140. La Manna G, Pizza F, Persici E, et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transplant 2011;26:1976-83
141. Lindner A, Fornadi K, Lazar AS, et al. Periodic limb movements in sleep are associated with stroke and cardiovascular risk factors in patients with renal failure. J Sleep Res 2012;21:297-307
142. Pullen SJ, Wall CA, Angstman ER, et al. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study. J Clin Sleep Med 2011;7:587-96
143. Picchietti D, Allen RP, Walters AS, et al. Restless legs syndrome: prevalence and impact in children and adolescents - the Peds REST study. Pediatrics 2007;120:253-66
144. Kotagal S, Silber MH. Childhood-onset restless legs syndrome. Ann Neurol 2004;56:803-7
145. Wagner ML, Walters AS, Fisher BC. Symptoms of attention-deficit/ hyperactivity disorder in adults with restless legs syndrome. Sleep 2004;27:1499-504
146. Chervin RD, Archbold KH, Dillon JE, et al. Associations between symptoms of inattention, hyperactivity, restless legs, and periodic leg movements. Sleep 2002;25:213-18
147. Picchietti DL, England SJ, Walters AS, et al. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 1998;13:588-94
148. Chervin RD, Dillon JE, Bassetti C, et al. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep 1997;20:1185-92
149. Li Y, Batool-Anwar S, Kim S, et al. Prospective study of restless legs syndrome and risk of erectile dysfunction. Am J Epidemiol 2013;177:1097-105
150. Gao X, Schwarzschild MA, O'Reilly EJ, et al. Restless legs syndrome and erectile dysfunction. Sleep 2010;33:75-9
151. Franco RA, Ashwathnarayan R, Deshpandee A, et al. The high prevalence of restless legs syndrome symptoms in liver disease in an academic-based hepatology practice. J Clin Sleep Med 2008;4:45-9
152. Winter AC, Schürks M, Berger K, et al. Migraine and restless legs syndrome in men. Cephalalgia 2013;33:130-5
153. Schürks M, Winter AC, Berger K, et al. Migraine and restless legs syndrome in women. Cephalalgia 2012;32:382-9
154. Seidel S, Bock A, Schlegel W, et al. Increased RLS prevalence in children and adolescents with migraine: a case-control study. Cephalalgia 2012;32:693-9
155. Lucchesi C, Bonanni E, Maestri M, et al. Evidence of increased restless legs syndrome occurrence in chronic and highly disabling migraine. Funct Neurol 2012;27:91-4
156. Chen PK, Fuh JL, Chen SP, Wang SJ. Association between restless legs syndrome and migraine. J Neurol Neurosurg Psychiatr 2010;81:524-8.
157. d'Onofrio F, Bussone G, Cologno D, et al. Restless legs syndrome and primary headaches: a clinical study. Neurol Sci., 2008, 29(Suppl 1): S169-72.
158. Rhode AM, Hö sing VG, Happe S, et al. Comorbidity of migraine and restless legs syndrome - a case-control study. Cephalalgia 2007;27:1255-60
159. Young WB, Piovesan EJ, Biglan KM. Restless legs syndrome and druginduced akathisia in headache patients. CNS Spectr 2003;8:450-6
160. Li Y, Munger KL, Batool-Anwar S, et al. Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women. Neurology 2012;78:1500-6
161. Vavrova J, Kemlink D, Sonka K, et al. Restless legs syndrome in Czech patients with multiple sclerosis: an epidemiological and genetic study. Sleep Med 2012;13:848-51
162. Aydar G, Kurt S, Karaer Unaldi H, Erkorkmaz U. Restless legs syndrome in multiple sclerosis. Eur Neurol 2011;65:302-6
163. Fragoso YD, Finkelsztejn A, Gomes S, et al. Restless legs syndrome and multiple sclerosis: a Brazilian multicenter study and meta-analysis of the literature. Arquivos de Neuro-Psiquiatria 2011;69:180-3
164. Deriu M, Cossu G, Molari A, et al. Restless legs syndrome in multiple sclerosis: a case-control study. Mov Disord 2009;24:697-701
165. Manconi M, Ferini-Strambi L, Filippi M, et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep 2008;31:944-52
166. Moreira NC, Damasceno RS, Medeiros CA, et al. Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients. Braz J Med Biol Res 2008;41:932-7
167. Manconi M, Fabbrini M, Bonanni E, et al. High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol 2007;14:534-9
168. Gómez-Choco MJ, Iranzo A, Blanco Y, et al. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler 2007;13:805-8
169. Auger C, Montplaisir J, Duquette P. Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis. Neurology 2005;65:1652-3
170. Plazzi G, Ferri R, Franceschini C, et al. Periodic leg movements during sleep in narcoleptic patients with or without restless legs syndrome. J Sleep Res 2012;21:155-62
171. Plazzi G, Ferri R, Antelmi E, et al. Restless legs syndrome is frequent in narcolepsy with cataplexy patients. Sleep 2010;33:689-94
172. Ferri R, Lanuzza B, Cosentino FI, et al. A single question for the rapid screening of restless legs syndrome in the neurological clinical practice. Eur J Neurol 2007;14:1016-21
173. Gao X, Schwarzschild MA, Wang H, Ascherio A. Obesity and restless legs syndrome in men and women. Neurology 2009;72:1255-61
174. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-41
175. Bhalsing K, Suresh K, Muthane UB, Pal PK. Prevalence and profile of Restless Legs Syndrome in Parkinson's disease and other neurodegenerative disorders: a case-control study. Parkinsonism Relat Disord 2013;19:426-30
176. Rajabally YA, Martey J. No association between neuropathy and restless legs in Parkinson's disease. Acta Neurol Scand 2013;127:216-20
177. Shin HY, Youn J, Yoon WT, et al. Restless legs syndrome in Korean patients with drug-naïve Parkinson's disease: a nation-wide study. Parkinsonism Relat Disord 2013;19:355-8
178. Angelini M, Negrotti A, Marchesi E, et al. A study of the prevalence of restless legs syndrome in previously untreated Parkinson's disease patients: absence of co-morbid association. J Neurol Sci 2011;310: 286-8
179. Gjerstad MD, Tysnes OB, Larsen JP. Increased risk of leg motor restlessness but not RLS in early Parkinson disease. Neurology 2011;77:1941-6
180. Gao X, Schwarzschild MA, O'Reilly EJ, et al. Restless legs syndrome and Parkinson's disease in men. Mov Disord 2010;25:2654-7
181. Guerreiro TM, Nishikawa DR, Ferreira LC, et al. Restless legs syndrome in Parkinson's disease: clinical characteristics and biochemical correlations. Arquivos de Neuro-Psiquiatria 2010;68:869-72
182. Lee JE, Shin HW, Kim KS, Sohn YH. Factors contributing to the development of restless legs syndrome in patients with Parkinson disease. Mov Disord 2009;24:579-82
183. Calzetti S, Negrotti A, Bonavina G, et al. Absence of co-morbidity of Parkinson disease and restless legs syndrome: a case-control study in patients attending a movement disorders clinic. Neurol Sci 2009; 30:119-22
184. Gómez-Esteban JC, Zarranz JJ, Tijero B, et al. Restless legs syndrome in Parkinson's disease. Mov Disord 2007;22:1912-16
185. Nomura T, Inoue Y, Miyake M, et al. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease. Mov Disord 2006;21:380-4
186. Krishnan PR, Bhatia M, Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord 2003;18:181-5
187. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002;59: 421-4
188. Faull KF, Guilleminault C, Berger PA, et al. Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia. Ann Neurol 1983;13:258-63
189. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet 2001;357:354-7
190. Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, et al. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Mov Disord 2008;23(Suppl 3):S548-59
191. Möller JC, Unger M, Stiasny-Kolster K, Oertel WH. Restless Legs Syndrome (RLS) and Parkinson's disease (PD) -Related disorders or different entities? J Neurol Sci. 2010, 289, 135-7.
192. Durmer JS, Quraishi GH. Restless legs syndrome, periodic leg movements, and periodic limb movement disorder in children. Pediatr Clin North Am 2011;58:591-620
193. Rajaram SS, Walters AS, England SJ, et al. Some children with growing pains may actually have restless legs syndrome. Sleep 2004;27:767-73
194. Picchietti DL, Stevens HE. Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med 2008;9:770-81
195. Davis ID, Baron J, O'Riordan MA, Rosen CL. Sleep disturbances in
196. Applebee GA, Guillot AP, Schuman CC, et al. Restless legs syndrome in pediatric patients with chronic kidney disease. Pediatr Nephrol 2009;24:545-8
197. Davis ID, Greenbaum LA, Gipson D, et al. Prevalence of sleep disturbances in children and adolescents with chronic kidney disease. Pediatr Nephrol 2012;27:451-9
198. Sinha R, Davis ID, Matsuda-Abedini M. Sleep disturbances in children and adolescents with non-dialysis-dependent chronic kidney disease. Arch Pediatr Adolesc Med 2009;163:850-5
199. Riar SK, Leu RM, Turner-Green TC, et al. Restless legs syndrome in children with chronic kidney disease. Pediatr Nephrol 2013;28:773-95
200. Byrne R, Sinha S, Chaudhuri KR. Restless legs syndrome: diagnosis and review of management options. Neuropsychiatr Dis Treat 2006;2:155-64
201. Hornyak M, Grossmann C, Kohnen R, et al. Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial. J Neurol Neurosurg Psychiatr 2008;79:823-5
202. Silber MH, Becker PM, Earley C, et al. Willis-Ekbom disease foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc 2013;88:977-86
203. Allen RP, Adler CH, Du W, et al. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. Sleep Med 2011;12:906-13
204. Cho YW, Allen RP, Earley CJ. Lower molecular weight intravenous iron dextran for restless legs syndrome. Sleep Med 2013;14:274-7
205. Earley CJ, Horska A, Mohamed MA, et al. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009;10:206-11
206. Aurora RN, Kristo DA, Bista SR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and metaanalyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 2012;35:1039-62
207. Garcia-Borreguero D, Kohnen R, Silber MH, et al. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med 2013;14: 675-84
208. Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol 2012;19:1385-96
209. Buchfuhrer MJ. Strategies for the treatment of restless legs syndrome. Neurotherapeutics 2012;9:776-90
210. Hayes WJ, Lemon MD, Farver DK. Gabapentin enacarbil for treatment of restless legs syndrome in adults. Ann Pharmacother 2012;46:229-39
211. Oertel W, Trenkwalder C, Benes H, et al. Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study. Lancet Neurol 2011;10:710-20
212. Garcia-Borreguero D, Allen RP, Kohnen R, et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 2007;8:520-30
213. Trenkwalder C, Hogl B, Benes H, Kohnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 2008;9:572-4
214. Hogl B, Garcia-Borreguero D, Kohnen R, et al. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol 2010;257:230-7
215. Hogl B, Garcia-Borreguero D, Trenkwalder C, et al. Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome. Sleep Med 2011;12:351-60
216. Garcia-Borreguero D, Hogl B, Ferini-Strambi L, et al. Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks. Mov Disord 2012;27:277-83
217. Benes H, Garcia-Borreguero D, Ferini-Strambi L, et al. Augmentation in the treatment of restless legs syndrome with transdermal rotigotine. Sleep Med 2012;13:589-97
218. Vetrugno R, La Morgia C, D'Angelo R, et al. Augmentation of restless legs syndrome with long-term tramadol treatment. Mov Disord 2007;22:424-7
219. Earley CJ, Allen RP. Restless legs syndrome augmentation associated with tramadol. Sleep Med 2006;7:592-3
220. Frenette E. Restless legs syndrome in children: a review and update on pharmacological options. Curr Pharm Des 2011;17:1436-42